Implantable insulin pump therapy: An unusual presentation of a catheter-related complication

Kevin B. Moore, Christopher D. Saudek, Alicia Greene, Alan Dackiw

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We report the case of a 63-year-old man who has a 19-year history of involvement in the implantable insulin pump program at Johns Hopkins University. After his most recent pump implantation in February 2004, his 24-h insulin requirement gradually increased from a baseline of 75 units to a peak of almost 500 units in June 2005. Surprisingly, insulin delivery from the pump and glycemic control remained satisfactory despite the dramatic change in insulin requirement. Laparotomy revealed a fibrous mass in the peritoneal cavity, with the track of the catheter extending into the mass. Insulin requirement declined post-resection of the mass and relocation of the catheter tip.

Original languageEnglish (US)
Pages (from-to)397-401
Number of pages5
JournalDiabetes Technology and Therapeutics
Volume8
Issue number3
DOIs
StatePublished - 2006

Fingerprint

Catheters
Pumps
Insulin
Therapeutics
Relocation
Peritoneal Cavity
Laparotomy

ASJC Scopus subject areas

  • Endocrinology
  • Medicine (miscellaneous)
  • Clinical Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Implantable insulin pump therapy : An unusual presentation of a catheter-related complication. / Moore, Kevin B.; Saudek, Christopher D.; Greene, Alicia; Dackiw, Alan.

In: Diabetes Technology and Therapeutics, Vol. 8, No. 3, 2006, p. 397-401.

Research output: Contribution to journalArticle

Moore, Kevin B. ; Saudek, Christopher D. ; Greene, Alicia ; Dackiw, Alan. / Implantable insulin pump therapy : An unusual presentation of a catheter-related complication. In: Diabetes Technology and Therapeutics. 2006 ; Vol. 8, No. 3. pp. 397-401.
@article{5d74d639867442e4950c0a5d6794c529,
title = "Implantable insulin pump therapy: An unusual presentation of a catheter-related complication",
abstract = "We report the case of a 63-year-old man who has a 19-year history of involvement in the implantable insulin pump program at Johns Hopkins University. After his most recent pump implantation in February 2004, his 24-h insulin requirement gradually increased from a baseline of 75 units to a peak of almost 500 units in June 2005. Surprisingly, insulin delivery from the pump and glycemic control remained satisfactory despite the dramatic change in insulin requirement. Laparotomy revealed a fibrous mass in the peritoneal cavity, with the track of the catheter extending into the mass. Insulin requirement declined post-resection of the mass and relocation of the catheter tip.",
author = "Moore, {Kevin B.} and Saudek, {Christopher D.} and Alicia Greene and Alan Dackiw",
year = "2006",
doi = "10.1089/dia.2006.8.397",
language = "English (US)",
volume = "8",
pages = "397--401",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Implantable insulin pump therapy

T2 - An unusual presentation of a catheter-related complication

AU - Moore, Kevin B.

AU - Saudek, Christopher D.

AU - Greene, Alicia

AU - Dackiw, Alan

PY - 2006

Y1 - 2006

N2 - We report the case of a 63-year-old man who has a 19-year history of involvement in the implantable insulin pump program at Johns Hopkins University. After his most recent pump implantation in February 2004, his 24-h insulin requirement gradually increased from a baseline of 75 units to a peak of almost 500 units in June 2005. Surprisingly, insulin delivery from the pump and glycemic control remained satisfactory despite the dramatic change in insulin requirement. Laparotomy revealed a fibrous mass in the peritoneal cavity, with the track of the catheter extending into the mass. Insulin requirement declined post-resection of the mass and relocation of the catheter tip.

AB - We report the case of a 63-year-old man who has a 19-year history of involvement in the implantable insulin pump program at Johns Hopkins University. After his most recent pump implantation in February 2004, his 24-h insulin requirement gradually increased from a baseline of 75 units to a peak of almost 500 units in June 2005. Surprisingly, insulin delivery from the pump and glycemic control remained satisfactory despite the dramatic change in insulin requirement. Laparotomy revealed a fibrous mass in the peritoneal cavity, with the track of the catheter extending into the mass. Insulin requirement declined post-resection of the mass and relocation of the catheter tip.

UR - http://www.scopus.com/inward/record.url?scp=33748433423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748433423&partnerID=8YFLogxK

U2 - 10.1089/dia.2006.8.397

DO - 10.1089/dia.2006.8.397

M3 - Article

C2 - 16800761

AN - SCOPUS:33748433423

VL - 8

SP - 397

EP - 401

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 3

ER -